CollPlant advances 3D bioprinted regenerative breast implants Medical
CollPlant, a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, has initiated a study in large animals for its 3D bioprinted regenerative breast implant program – addressing the reported $2.8 billion global breast implant market.